Polycystic ovary syndrome (PCOS) is widely accepted as the most common endocrine
abnormality in women of childbearing age and may be accompanied by dyslipidemia …

Polycystic ovary syndrome (PCOS) has been traditionally perceived as a reproductive
disorder due to its most common presentation with menstrual dysfunction and infertility …

Gut microbiota has been proved to be involved in the occurrence and development of many
diseases, such as type 2 diabetes, obesity, coronary heart disease, etcetera. It provides a …

Background: Cardiovascular disease (CVD) is one of the debilitating consequences of
polycystic ovary syndrome (PCOS). Early diagnosis of metabolic syndrome (MetS) with a …

Background: Polycystic ovary syndrome (PCOS) contributes to metabolic and endocrine
complications for women of reproductive age. We set out to assess the relationship between …

Background: Insulin resistance (IR) is common in women with polycystic ovary syndrome
(PCOS). Metabolic syndrome (MS) involves IR, arterial hypertension, dyslipidemia, and …

This study was performed to assess the impact of lipid accumulation product (LAP) and
visceral adiposity index (VAI) on clinical, hormonal, and metabolic parameters in lean …

Background and aim Visceral adiposity index (VAI) is reportedly beneficial in predicting
cardiovascular disease (CVD) and metabolic syndrome (MetS). However, long-term studies …

Background The presence of hypertension significantly increases the risk of diabetes,
particularly type 2 diabetes. Recently, Visceral Adiposity Index (VAI) has been introduced as …

Objective Polycystic ovary syndrome (PCOS) is a recognized risk factor for nonalcoholic fatty
liver disease (NAFLD). The aims of this study were to investigate the prevalence and factors …